Home Banking & Finance Regeneron announces Q4 earnings

Regeneron announces Q4 earnings

SHARE

The Greenburgh biotech company announces sales of its drug Eylea rose 39 percent in the fourth quarter.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email